Dr. Nevadunsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1695 Eastchester Rd
Bronx, NY 10461Phone+1 718-405-8082
Summary
- Dr. Nicole Nevadunsky is an obstetrician/gynecologist in Bronx, NY and is affiliated with multiple hospitals in the area, including Montefiore Medical Center and NYC Health + Hospitals / Coney Island. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 15 years. She specializes in gynecologic oncology and hospice & palliative medicine and is experienced in reproductive and sexual endocrinology, general obstetrics and gynecology, maternal and fetal medicine, gynecologic oncology, and urogynecology and pelvic reconstructive surgery.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 2002 - 2006
- Rutgers Robert Wood Johnson Medical SchoolClass of 2002
- Rutgers CollegeB.A., Magna cum Laude, 1993 - 1997
- Brigham and Women’s HospitalFellowship, Gynecologic Oncology
Certifications & Licensure
- NY State Medical License 2003 - 2025
- MA State Medical License 2007 - 2010
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Second Prize Award, Young Investigators Symposium Montefiore Medical Center, Albert Einstein College of Medicine, 2016
- Fourth Prize Award, Young Investigators Symposium Montefiore Medical Center, Albert Einstein College of Medicine, 2011
- Springer Best Abstract Prize at the World Robotic Gynecology Congress 2009
- Join now to see all
Clinical Trials
- Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer Start of enrollment: 2009 Jan 16
- Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2016 Mar 28
- Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer Start of enrollment: 2016 May 03
Publications & Presentations
PubMed
- Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomiz...Matthew A Powell, David Cibula, David M O'Malley, Ingrid Boere, Mark S Shahin
Gynecologic Oncology. 2024-11-11 - 1 citationsReduced healthcare access contributes to delay of care in endometrial cancer.Alexander J Fife, Anna J Najor, Tori B Aspir, Kaitlin E Haines, Nicole A Vilardo
Gynecologic Oncology. 2024-03-01 - Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled...Annika Auranen, Matthew A Powell, Vladyslav Sukhin, Lisa M Landrum, Graziana Ronzino
Therapeutic Advances in Medical Oncology. 2024-01-01
Journal Articles
- Utilization of intraperitoneal chemotherapy for optimally cytoreduced advanced stage epithelial ovarian cancer: A 10-year single institution experience with a racially...Miller, E, Tymon-Rosaria, J, Xianhong, X, Xianon, X, Gressel, G, Miller, D, Kuo, Y, Nevadunsky, N, Gynecologic Oncology, 1/1/2017
- The gynecologic oncology fellowship interview process: challenges and potential areas for improvementGressel, G, Van Arsdale, A, Dioun, S, Goldberg, G, Nevadunsky, N, Gynecologic Oncology Reports, 1/1/2017
- Speaking the same language: a feasibility trial for a novel visual communication tool for oncologist-patient treatment discusssionsZanartu, C, Camacho, F, Nevadunsky, N, Martin, B, Kornblum, N, Chuy, J, Perez-Soler, R, Psycho-Oncology, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Racial disparity in emergency department diagnosis of gynecologic malignanciesMarcus, J, Rosenbaum, D, Van Arsdale, A, Barrera, R, Rapikin, B, Frimer, M, Goldberg, G, Nevadunsky, N, Gynecologic Oncology, 1/1/2016
- Association between statin use and disease-specific endometrial cancer survivalEinstein, M, Kaur, G, Strickler, H, Moadel, A, Girda, E, Goldberg, G, Nevadunsky, N, Gynecologic Oncology, 1/1/2015
- Feasiblity of office hysteroscopy for evaluation of women with postmenopausal bleeding and association with improved pathological diagnosisShaw, J, Chudnoff, S, Levie, M, Einstein, M, Goldberg, G, Nevadunsky, N, Proceedings of the 106th annual Meeting of the American Association for Cancer Research; March 31-Apr 4; Philadelphia, Pennsylvania. Philadelphia (PA):AACR, 1/1/2015
- Join now to see all
Lectures
- Cervical Cancer Prevention: Impact of Extended Testing Interval1/1/2017
- Endometrial Cancer Disparities, Metabolic Factors and Lifestyle Interventions1/1/2017
- Early palliative care is associated with improved quality of end-of-life care for women with high risk gynecologic malignanciesWashington, DC - 1/1/2017
- Join now to see all
Press Mentions
- NIH Study Shows Correlation Between Hair Relaxers and Uterine CancerOctober 28th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: